Overview
Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults
Status:
Completed
Completed
Trial end date:
2007-07-01
2007-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Subjects will be asked to participate in a four day research study of the immune system effects and safety of short-term acute dosing of Cold-fX. The purpose of the study is to determine the effects of acute dosing of Cold-fX for 3 days on the immune system compared to a placebo (dummy pill). Safety of the acute dosing will be determined through various blood tests carried out during the study.Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
CV Technologies
Criteria
Inclusion Criteria:- General good health
- Willing to adhere to the requirements of the protocol, including availability for
follow-up visits
- Willing and able to sign written informed consent
Exclusion Criteria:
- Individuals with known HIV infection
- Individuals with malignancy
- Individuals with a history or symptoms of unstable cardiovascular disease
- Individuals with renal abnormalities
- Individuals having a history or symptoms of pulmonary disease
- Individuals having acute or active chronic liver disease
- Individuals having neurologic or psychiatric disease
- Individuals having active tuberculosis
- Individuals having multiple sclerosis
- Individuals having bleeding disorders
- Individuals with planned surgery over the course of the trial or having had major
surgery in the past 6 mo.
- Individuals with a history of alcohol/drug abuse
- Pregnant and lactating women
- Individuals on prescribed medication with the exception of oral contraceptives
- Individuals with Crohn's disease, Lupus, Rheumatoid arthritis, Colitis or any other
auto-immune disease
- Individuals using natural health products or dietary supplements for 2 weeks prior and
during the trial
- Individuals having allergies to ginseng or to any known component of the drug product
or placebo
- Smokers (smoking > 10 cigarettes/day)
- Alcoholics (drinking > 10 drinks/week)